Analysts Set Axsome Therapeutics, Inc. (NASDAQ:AXSM) Price Target at $134.00
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has received a consensus rating of “Buy” from the sixteen ratings firms that are covering the stock, MarketBeat.com reports. Sixteen research analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have covered the stock in the last year […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has received a consensus rating of “Buy” from the sixteen ratings firms that are covering the stock, MarketBeat.com reports. Sixteen research analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have covered the stock in the last year […]
